MeiraGTx Holdings (MGTX) Non-Current Deffered Revenue (2017 - 2025)

MeiraGTx Holdings (MGTX) reported Non-Current Deffered Revenue of $65.1 million for Q4 2025, up 13.1% on a YoY basis from $57.6 million in Q4 2024, and up 1.42% quarter-over-quarter from $64.2 million in Q3 2025.

MeiraGTx Holdings (MGTX) Non-Current Deffered Revenue (2017 - 2025) Analysis & Trends

MeiraGTx Holdings has reported Non-Current Deffered Revenue for 9 years, with the latest figure at $65.1 million in Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Deffered Revenue rose 13.1% year-over-year to $65.1 million; the trailing twelve-month figure through Dec 2025 stood at $65.1 million (up 13.1% YoY), and the FY2025 full-year result was $65.1 million, up 13.1% from the prior year.
  • Non-Current Deffered Revenue for Q4 2025 stood at $65.1 million, up from $64.2 million in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $65.1 million in Q4 2025, with the low at $15.5 million in Q3 2022.
  • Historically, Non-Current Deffered Revenue has averaged $42.2 million across 5 years, with a median of $41.2 million in 2021.
  • Annual changes were most pronounced in 2022 — Non-Current Deffered Revenue tumbled 52.33% — and 2024, when it surged 153.99%.
  • MeiraGTx Holdings' Non-Current Deffered Revenue stood at $43.0 million in 2021, then tumbled by 36.26% to $27.4 million in 2022, then rose by 23.99% to $34.0 million in 2023, then surged by 69.26% to $57.6 million in 2024, then advanced by 13.1% to $65.1 million in 2025.
  • The last three Non-Current Deffered Revenue figures came in at $65.1 million (Q4 2025), $64.2 million (Q3 2025), and $63.0 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 MeiraGTx Holdings 910.47 Mn 844.54 Mn 74.89 Mn 65.12 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 65.12 Mn
Sep 30, 2025 64.21 Mn
Jun 30, 2025 63.04 Mn
Mar 31, 2025 59.62 Mn
Dec 31, 2024 57.58 Mn
Sep 30, 2024 58.90 Mn
Jun 30, 2024 53.76 Mn
Mar 31, 2024 53.33 Mn
Dec 31, 2023 34.02 Mn
Sep 30, 2023 23.19 Mn
Jun 30, 2023 25.36 Mn
Mar 31, 2023 26.43 Mn
Dec 31, 2022 27.44 Mn
Sep 30, 2022 15.49 Mn
Jun 30, 2022 21.34 Mn
Mar 31, 2022 37.28 Mn
Dec 31, 2021 43.05 Mn
Sep 30, 2021 32.49 Mn
Jun 30, 2021 39.33 Mn
Mar 31, 2021 43.30 Mn